The Current Ratio as of September 2024 (TTM) for Repligen Corporation (RGEN) is 6.65

According to Repligen Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 6.65. This represents a change of 17.05% compared to the average of 5.68 of the last 4 quarters.

Repligen Corporation (RGEN) Historical Current Ratio (quarterly & annually)

How has RGEN Current Ratio performed in the past?

The mean historical Current Ratio of Repligen Corporation over the last ten years is 6.17. The current 6.65 Current Ratio has changed 10.68% with respect to the historical average. Over the past ten years (40 quarters), RGEN's Current Ratio was at its highest in in the September 2019 quarter at 16.03. The Current Ratio was at its lowest in in the September 2017 quarter at 1.95.

Repligen Corporation (RGEN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Repligen Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Repligen Corporation (RGEN) Average Current Ratio

How has RGEN Current Ratio performed in the past?

The current Current Ratio of Repligen Corporation (RGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Repligen Corporation (RGEN) Current Ratio vs. Peers

How is RGEN’s Current Ratio compared to its peers?

Repligen Corporation’s Current Ratio is greater than Intuitive Surgical, Inc. (5.15), greater than ResMed Inc. (2.59), greater than Merit Medical Systems, Inc. (6.24), greater than ICU Medical, Inc. (2.40), greater than The Cooper Companies, Inc. (1.99), greater than West Pharmaceutical Services, Inc. (2.34), greater than Becton, Dickinson and Company (1.85), greater than Hologic, Inc. (3.99), greater than Teleflex Incorporated (2.58), greater than Haemonetics Corporation (3.76), greater than AngioDynamics, Inc. (2.12), greater than AptarGroup, Inc. (1.36), greater than Envista Holdings Corporation (2.22),

Build a custom stock screener for Repligen Corporation (RGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repligen Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Repligen Corporation (RGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Repligen Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.